These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10580755)

  • 1. Pharmacokinetics and metabolic effects of high-dose growth hormone administration in healthy adult men.
    Tanaka T; Seino Y; Fujieda K; Igarashi Y; Yokoya S; Tachibana K; Ogawa Y
    Endocr J; 1999 Aug; 46(4):605-12. PubMed ID: 10580755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-response studies with biosynthetic human growth hormone (GH) in GH-deficient patients.
    Jørgensen JO; Flyvbjerg A; Lauritzen T; Alberti KG; Orskov H; Christiansen JS
    J Clin Endocrinol Metab; 1988 Jul; 67(1):36-40. PubMed ID: 3288652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-I in man enhances lipid mobilization and oxidation induced by a growth hormone pulse.
    Bianda TL; Hussain MA; Keller A; Glatz Y; Schmitz O; Christiansen JS; Alberti KG; Froesch ER
    Diabetologia; 1996 Aug; 39(8):961-9. PubMed ID: 8858219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability and bioactivity of intravenous vs subcutaneous infusion of growth hormone in GH-deficient patients.
    Laursen T; Møller J; Jørgensen JO; Orskov H; Christiansen JS
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):333-9. PubMed ID: 8949572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic effects of growth hormone administered subcutaneously once or twice daily to growth hormone deficient adults.
    Laursen T; Jørgensen JO; Christiansen JS
    Clin Endocrinol (Oxf); 1994 Sep; 41(3):337-43. PubMed ID: 7525120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone dose regimens in adult GH deficiency: effects on biochemical growth markers and metabolic parameters.
    Møller J; Jørgensen JO; Lauersen T; Frystyk J; Naeraa RW; Orskov H; Christiansen JS
    Clin Endocrinol (Oxf); 1993 Oct; 39(4):403-8. PubMed ID: 7507009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.
    Laursen T; Jørgensen JO; Jakobsen G; Hansen BL; Christiansen JS
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2410-8. PubMed ID: 7543114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two weeks of daily injections and continuous infusion of recombinant human growth hormone (GH) in GH-deficient adults: I. Effects on insulin-like growth factor-I (IGF-I), GH and IGF binding proteins, and glucose homeostasis.
    Johansson JO; Oscarsson J; Bjarnason R; Bengtsson BA
    Metabolism; 1996 Mar; 45(3):362-9. PubMed ID: 8606645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability and bioactivity of three different doses of nasal growth hormone (GH) administered to GH-deficient patients: comparison with intravenous and subcutaneous administration.
    Laursen T; Grandjean B; Jørgensen JO; Christiansen JS
    Eur J Endocrinol; 1996 Sep; 135(3):309-15. PubMed ID: 8890721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and metabolic effects of growth hormone injected subcutaneously in growth hormone deficient patients: thigh versus abdomen.
    Laursen T; Jørgensen JO; Christiansen JS
    Clin Endocrinol (Oxf); 1994 Mar; 40(3):373-8. PubMed ID: 7514513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptin is suppressed during infusion of recombinant human insulin-like growth factor I (rhIGF I) in normal rats.
    Böni-Schnetzler M; Hauri C; Zapf J
    Diabetologia; 1999 Feb; 42(2):160-6. PubMed ID: 10064095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lowered ghrelin levels in acromegaly—normalization after treatment].
    Kozakowski J; Rabijewski M; Zgliczyński W
    Endokrynol Pol; 2005; 56(6):862-70. PubMed ID: 16821203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of administration of human growth hormone on the plasma growth hormone, cortisol, glucose, and free fatty acid response to insulin: evidence for growth hormone autoregulation in man.
    Abrams RL; Grumbach MM; Kaplan SL
    J Clin Invest; 1971 Apr; 50(4):940-50. PubMed ID: 4926262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulsatile versus continuous intravenous administration of growth hormone (GH) in GH-deficient patients: effects on circulating insulin-like growth factor-I and metabolic indices.
    Jørgensen JO; Møller N; Lauritzen T; Christiansen JS
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1616-23. PubMed ID: 2189886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbohydrate metabolism during growth hormone treatment and after discontinuation of growth hormone treatment in girls with Turner syndrome treated with once or twice daily growth hormone injections.
    Sas T; de Muinck Keizer-Schrama S; Aanstoot HJ; Stijnen T; Drop S
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):741-7. PubMed ID: 10848879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of octreotide on insulin-like growth factor I and metabolic indices in growth hormone-treated growth hormone-deficient patients.
    Laursen T; Jørgensen JO; Orskov H; Møller J; Harris AG; Christiansen JS
    Acta Endocrinol (Copenh); 1993 Nov; 129(5):399-408. PubMed ID: 7506470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of growth hormone replacement therapy on overnight metabolic fuels in hypopituitary patients.
    Kousta E; Chrisoulidou A; Lawrence NJ; Anyaoku V; Al-Shoumer KA; Johnston DG
    Clin Endocrinol (Oxf); 2000 Jan; 52(1):17-24. PubMed ID: 10651749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic effects and pharmacokinetics of a growth hormone pulse in healthy adults: relation to age, sex, and body composition.
    Vahl N; Møller N; Lauritzen T; Christiansen JS; Jørgensen JO
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3612-8. PubMed ID: 9360515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response studies on the metabolic effects of a growth hormone pulse in humans.
    Møller N; Schmitz O; Pørksen N; Møller J; Jørgensen JO
    Metabolism; 1992 Feb; 41(2):172-5. PubMed ID: 1736039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of 2 weeks high dose growth hormone treatment on basal and insulin stimulated substrate metabolism in humans.
    Møller N; Møller J; Jørgensen JO; Ovesen P; Schmitz O; Alberti KG; Christiansen JS
    Clin Endocrinol (Oxf); 1993 Nov; 39(5):577-81. PubMed ID: 8252748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.